Arvinas (ARVN) Accounts Payables (2017 - 2026)

Arvinas' (ARVN) quarterly Accounts Payables came in at $62.3 million in Q1 2026, down 12.38% year-on-year from $71.1 million in Q1 2025, and down 10.36% quarter-over-quarter from $69.5 million in Q4 2025.

Arvinas (ARVN) Accounts Payables (2017 - 2026) Analysis & Trends

Arvinas' Accounts Payables history runs 10 years deep, the most recent figure standing at $62.3 million for Q1 2026.

  • On a quarterly basis, Accounts Payables fell 12.38% year-over-year to $62.3 million in Q1 2026; TTM through Mar 2026 was $62.3 million, a 12.38% decrease from a year earlier, with the FY2025 full-year figure at $69.5 million, down 3.2% from the prior year.
  • Accounts Payables slipped to $62.3 million in Q1 2026 per ARVN's latest filing, from $69.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $92.2 million in Q4 2023 and bottomed at $8.6 million in Q1 2022.
  • The 5-year median for Accounts Payables is $71.1 million (2025), against an average of $65.5 million.
  • Across the five-year window, Accounts Payables soared 963.87% in 2022 and tumbled 32.01% in 2025, its largest moves.
  • Year by year, Accounts Payables stood at $74.7 million in 2022, then increased by 23.43% to $92.2 million in 2023, then decreased by 22.13% to $71.8 million in 2024, then fell by 3.2% to $69.5 million in 2025, then fell by 10.36% to $62.3 million in 2026.
  • Per Business Quant, the three latest ARVN Accounts Payables figures stand at $62.3 million (Q1 2026), $69.5 million (Q4 2025), and $55.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Arvinas 519.68 Mn -95.22 Mn - 62.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 62.30 Mn
Dec 31, 2025 69.50 Mn
Sep 30, 2025 55.50 Mn
Jun 30, 2025 53.10 Mn
Mar 31, 2025 71.10 Mn
Dec 31, 2024 71.80 Mn
Sep 30, 2024 75.90 Mn
Jun 30, 2024 78.10 Mn
Mar 31, 2024 76.40 Mn
Dec 31, 2023 92.20 Mn
Sep 30, 2023 91.00 Mn
Jun 30, 2023 74.80 Mn
Mar 31, 2023 66.00 Mn
Dec 31, 2022 74.70 Mn
Sep 30, 2022 49.70 Mn
Jun 30, 2022 42.10 Mn
Mar 31, 2022 8.60 Mn
Dec 31, 2021 54.40 Mn
Sep 30, 2021 4.67 Mn
Jun 30, 2021 4.98 Mn